Cognition Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of December 2021: 0.53x

Cognition Therapeutics Inc cash flow reinvestment rate. Cognition Therapeutics Inc (CGTX) has a Cash Flow Reinvestment Rate of 0.53x as of December 2021, reinvesting $54.00K (capex $27.00K plus investments $-27.00K) from operating cash flow of $101.00K. Explore cash flow to debt ratio of Cognition Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.53x

(Capex + Investments) / Operating CF

Total Reinvested

$54.00K

Capex + Investments

Operating Cash Flow

$101.00K

USD

Capital Expenditures

$27.00K

USD

Cognition Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)

Cognition Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Cognition Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Cognition Therapeutics Inc generate cash.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow